ArticleJournal of translational medicine2025
From biomarker to clinical utility: translating the advanced lung cancer inflammation index into a machine learning-driven risk stratification tool for colorectal cancer.
Article in Journal of translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Development and validation of a cross-sectional risk screening nomogram for carotid plaque based on routine health examination data and the triglyceride-glucose-waist-to-hip ratio.Frontiers in endocrinology · 2026Article
- Optimizing cardiovascular disease diagnosis through machine learning models integrating oxidized low-density lipoprotein and routine clinical indicators.Frontiers in endocrinology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundBoth nutrition and inflammation have been implicated in the pathogenesis of colorectal cancer (CRC), but most previous studies have examined these factors separately. This study aimed to explore the combined association of inflammation and nutritional status with CRC.
methodsThis study selected 101,316 subjects from the National Health and Nutrition Survey (NHANES) conducted from 1999 to 2018. First, weighted logistic regression was used to measure the association between the advanced lung cancer inflammation index (ALI) and CRC. Then, restricted cubic splines (RCS) were used to capture the dose-response curve, and the predictive power of the model was calibrated by the ROC curve. Subsequently, robustness was verified through subgroup and interaction analyses. Furthermore, random forest analysis combined with the Boruta algorithm was employed to identify CRC-related factors. Subsequently, a machine learning(ML) prediction framework is constructed, and the black box of the optimal model is disassembled using SHAP values to endow it with interpretability.
resultsIn the fully adjusted model, each unit increase in log-transformed ALI was associated with a 20.9% reduction in CRC risk (OR = 0.791; 95% CI: 0.628–0.997; p = 0.047). Participants in the highest log-ALI quartile had a 46.2% lower risk compared to those in the lowest quartile (OR = 0.538; 95% CI: 0.344–0.842; P = 0.007). The fully adjusted model demonstrated strong discriminative ability (AUC = 0.848). RCS analysis confirmed a linear dose-response relationship (P for nonlinearity = 0.731). The robustness of these findings was supported by subgroup and sensitivity analyses. Random forest analysis coupled with the Boruta algorithm identified log-ALI as a strong predictor. Among seven machine learning models evaluated, the LightGBM algorithm achieved the highest and most stable predictive performance (AUC = 0.870). SHAP analysis confirmed log-ALI as the most important protective feature.
conclusionThis study demonstrates that higher ALI levels, indicative of better nutritional and inflammatory status, are significantly associated with a lower risk of CRC. The optimized ML model based on ALI shows promise as a cost-effective tool for CRC risk stratification.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.